Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
6,43 USD | -1,68% | -0,62% | +13,81% |
Métier
Nombre d'employés: 145
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Targeted Protein Degradation
100,0
%
| 31 | 100,0 % | 21 | 100,0 % | -33,25% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 31 | 100,0 % | 21 | 100,0 % | -33,25% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 14/09/20 |
Kendra Adams
DFI | Director of Finance/CFO | 48 | 20/11/20 |
Chief Tech/Sci/R&D Officer | - | 01/01/21 | |
Stewart Fisher
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/05/16 |
Leonard Reyno
CTO | Chief Tech/Sci/R&D Officer | 61 | 10/07/23 |
Courtney Solberg
IRC | Investor Relations Contact | - | - |
Mark Mossler
AUD | Comptroller/Controller/Auditor | 51 | 01/06/23 |
Scott Boyle
PRN | Corporate Officer/Principal | 46 | 01/01/22 |
Adrian Bignami
PRN | Corporate Officer/Principal | - | 01/04/21 |
Jolie Siegel
LAW | General Counsel | 47 | 01/06/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Bruce Downey
CHM | Chairman | 76 | 01/12/15 |
Glenn Dubin
BRD | Director/Board Member | 67 | 12/03/21 |
Bihua Chen
PRN | Corporate Officer/Principal | 55 | 01/12/15 |
Donna Grogan
BRD | Director/Board Member | 67 | 29/07/22 |
Owen Hughes
BRD | Director/Board Member | 49 | 20/11 |
Kenneth Anderson
FOU | Founder | 72 | 01/10/15 |
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 14/09/20 |
Malcolm Salter
BRD | Director/Board Member | 84 | 01/12/15 |
Utpal Koppikar
BRD | Director/Board Member | 53 | 16/03/22 |
Laura Bessen
BRD | Director/Board Member | 61 | 29/07/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 68 600 669 | 60 834 824 ( 88,68 %) | 0 | 88,68 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+13,81% | 450 M | |
+26,28% | 42,68 Md | |
-3,99% | 42,4 Md | |
+45,32% | 40,04 Md | |
-6,20% | 28,31 Md | |
+6,36% | 24,94 Md | |
-21,47% | 18,96 Md | |
+27,58% | 12,3 Md | |
-2,75% | 11,95 Md | |
-2,02% | 11,55 Md |
- Bourse
- Actions
- Action CCCC
- Société C4 Therapeutics, Inc.